ProQR Therapeutics (PRQR) Current Assets (2021 - 2025)

ProQR Therapeutics' Current Assets history spans 4 years, with the latest figure at $164.4 million for Q4 2024.

  • For Q4 2024, Current Assets rose 26.29% year-over-year to $164.4 million; the TTM value through Dec 2024 reached $164.4 million, up 26.29%, while the annual FY2024 figure was $166.5 million, 27.23% up from the prior year.
  • Current Assets for Q4 2024 was $164.4 million at ProQR Therapeutics, up from $130.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $219.1 million in Q4 2021 and bottomed at $130.2 million in Q4 2023.
  • The 4-year median for Current Assets is $161.0 million (2022), against an average of $167.8 million.
  • The largest annual shift saw Current Assets decreased 28.06% in 2022 before it rose 26.29% in 2024.
  • A 4-year view of Current Assets shows it stood at $219.1 million in 2021, then decreased by 28.06% to $157.6 million in 2022, then dropped by 17.4% to $130.2 million in 2023, then grew by 26.29% to $164.4 million in 2024.
  • Per Business Quant, the three most recent readings for PRQR's Current Assets are $164.4 million (Q4 2024), $130.2 million (Q4 2023), and $157.6 million (Q4 2022).